The Dexcel Pharma-backed immunotherapy discovery technology developer’s latest round was led by Koch Disruptive Technologies and took its overall funding to $295m.
Author: Liwen-Edison Fu
NuScale powers up with $152m
Several corporate investors have backed a series A5 round for the clean nuclear energy technology developer that leverages Oregon State University research.
GCV Powerlist 2021: #10 Meghan Sharp
The top 25: Meghan Sharp, global head, BP Ventures
SmartHR smartens up with $115m series D
Undisclosed investors helped the Digital Garage, Nissen and Tokio Marine & Nichido-backed human resources software provider raise fresh funding at a $1.56bn valuation.
GCV Powerlist 2020: Crispin Leick
26 – 100 in alphabetical order: Crispin Leick, managing director, EnBW New Ventures